Added to YB: 2025-07-29
Pitch date: 2025-07-25
000538.SZ [neutral]
Yunnan Baiyao Group Co.,Ltd
+0.49%
current return
Author Info
Panda Perspectives helps manage a China Long-only and an Asia Pacific long/short funds with PACAT Capital Management in Hong Kong. Sign up for the newsletter.
Company Info
Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.
Market Cap
CNY 100.9B
Pitch Price
CNY 55.56
Price Target
N/A
Dividend
2.10%
EV/EBITDA
16.59
P/E
20.26
EV/Sales
2.18
Sector
Pharmaceuticals
Category
growth
Heritage to Hardware: Traditional Chinese Medicine’s Leap into Digital Health - Yunnan Baiyao Group
000538.SZ (quick overview): Yunnan Baiyao, founded 1902, leverages secret TCM formula with strong IP protection to build diversified healthcare platform. Expanded beyond traditional medicine into consumer health and pharmaceuticals. Premium pricing power reflects strong brand equity. Strategic advantages: proprietary formula exclusivity, brand strength, scientific validation of TCM with modern standards.
Read full article (3 min)